“Market research studies or revisions carried out in large-scale Fluorescent in Situ Hybridization (FISH) Market reports help businesses gain knowledge about what already exists in the market, what the market is looking forward to, the competitive background and the steps to be taken to outperform the competitors. This market report considers various factors that have a direct or indirect influence on business growth which includes historical data, current market trends, environment, technological innovations, upcoming technologies, and technical advancements in the Fluorescent in Situ Hybridization (FISH) s Market industry. Extensive Fluorescent in Situ Hybridization (FISH) Market research reports prove to be the backbone of business success in any field.
Different markets, market strategies, trends, future products, and rising opportunities are taken into account while studying the market and preparing the Fluorescent in Situ Hybridization (FISH) Market report. The fact that competitive analysis is a key aspect of any market research report is carefully explored in this market report and therefore many points are covered in this report including strategic profiling of key players in the market, analysis of core competencies of key players, and drawing of the competitive landscape for market. The universal Fluorescent in Situ Hybridization (FISH) s Market analysis report offers a continuous forward-looking growth program, to ensure business success which is critical for organizations.
Data Bridge Market Research analyzes that the global Fluorescent in Situ Hybridization (FISH) market is expected to reach a value of USD 1,830.55 million by 2030, at a CAGR of 8.2% during the forecast period.
Explore Further Details about This Research Fluorescent in Situ Hybridization (FISH) Market Report https://www.databridgemarketresearch.com/reports/global-fluorescent-in-situ-hybridization-fish-market
|
REPORT METRIC |
DETAILS |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Year |
2021 (Customizable to 2015 – 2020) |
|
Quantitative Units |
Revenue in USD Million, and Pricing in USD |
|
Segments Covered |
By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland, rest of Europe, China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan, rest of Asia-Pacific, South Africa, Saudi Arabia, Bahrain, U.A.E, Kuwait, Oman, Qatar, Egypt, rest of Middle East and Africa, Brazil, Argentina, and rest of South America |
|
Market Players Covered |
Thermo Fisher Scientific Inc., Bio-Techne, Abbott, Agilent Technologies, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Abnova Corporation, BioDot, Biocare Medical, LLC, Abcam plc., Sysmex Asia Pacific Pte Ltd (a subsidiary of Sysmex Corporation), BIOZOL Diagnostics Vertrieb GmbH, Zytomed Systems GmbH, Genemed Biotechnologies, Inc., Bio SB, BioGenex, Excilone, MetaSystems, Kaneka Eurogentec S.A., BioCat GmbH, and Leica Biosystems Nussloch GmbH among others |
Market Definition
A molecular cytogenetic technique called Fluorescence in Situ Hybridization (FISH) enables the localization of a particular DNA sequence or an entire chromosome in a cell. It is used to diagnose genetic disorders, map genes, identify chromosomal anomalies, and may also be used to compare how the genes on different chromosomes in related species are organized. While performing FISH, the double helix structure is unwound and all probes connected to fluorescent molecules are bound to a particular sequence of sample DNA that can be seen under a fluorescence microscope.
FISH is frequently used for diagnostic purposes in oncology, preventative and reproductive health, and genomic and cell biology research. It is the industry-recognized method for finding infectious illnesses and chromosomal abnormalities. However, strict regulations and standards for the approval of FISH products and probes are expected to restrain the market growth.
Global Fluorescent in Situ Hybridization (FISH) Market Dynamics
This section deals with the understanding of market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Burden of Genetic Disorders as Well as Cancer
Genetic abnormalities are uncommon as a whole but are very frequent as individual ailments. Gene changes are the cause of all cancer. Just 5% to 10% of cancers are genetically predisposed. Nevertheless, when the same cancer types run in families, heredity may occasionally seem to be the cause of cancer. Hematologic and solid cancers are both heterogeneous diseases with various genetic abnormalities. An increasing number of genomic abnormalities such as gain, loss, or rearrangement of chromosomal fragments and gene mutations, are driving factors in the pathogenesis of various malignancies as a result of the extensive investigations into the relationship between genomic instability and disease pathogenesis conducted over the last two decades. The clinical diagnosis of different chromosomal abnormalities, including deletions, duplications, and translocations, depends on FISH and other in situ hybridization techniques, which drives market growth.
- Innovation and Advancements in FISH Products
The most reliable method for finding specific DNA sequences, diagnosing genetic illnesses, mapping genes, and discovering new oncogenes or genetic abnormalities causing various cancers is FISH. Recent advancements in the technology have made it possible to screen the entire genome concurrently utilizing array-based methods such as comparative genomic hybridization or multiplex FISH with multicolor whole chromosome probes. In the fight against genetic diseases, FISH has fundamentally transformed the field of cytogenetics and is now acknowledged as a trustworthy diagnostic and research tool, which drives market growth.
Restraint
- High Cost of FISH Testing
The macromolecule recognition technique known as FISH relies on the complementary nature of DNA or DNA/RNA double strands. The FISH test “maps” the genetic material present in human cells, including particular genes or gene segments. A FISH test is helpful for diagnosing some types of cancer because it can find genetic abnormalities linked to the disease. Cost issues are of utmost relevance in the modern molecular diagnostic laboratory. In addition to enabling a laboratory to handle increased test volumes and throughput, automation of complicated molecular assays also significantly reduces the cost of testing from the standpoint of reagent expenses, which restrains market growth.
Opportunity
- Rising Public Awareness about the Early Detection of Genetic Abnormalities
Genetic testing aids patients in making important decisions in the prevention, treatment, or early detection of hereditary disorders. Low awareness of the importance of genetic testing contributes to the increase in the incidence of hereditary disorders.
A genetic disorder is a health condition that is inherited by a person, usually caused by mutations in the DNA or changes in the number or overall structure of chromosomes. Several types of commonly known diseases have been determined to be related to hereditary gene mutations.
Henceforth, the rising awareness about the early detection of genetic disorders using the FISH technique helps in the diagnosis of genetic diseases, gene mapping, and identification of novel oncogenes or genetic aberrations contributing to various types of cancers and genetic disorders, which provides the opportunity for market growth.
Key questions answered in the Fluorescent in Situ Hybridization (FISH) Market are:
- What is Fluorescent in Situ Hybridization (FISH) Market?
- What was the Fluorescent in Situ Hybridization (FISH) Market size in 2022?
- What are the different segments of the Fluorescent in Situ Hybridization (FISH) Market?
- What growth strategies are the players considering to increase their presence in Fluorescent in Situ Hybridization (FISH) Market?
- What are the upcoming industry applications and trends for the Fluorescent in Situ Hybridization (FISH) Market?
- What are the recent industry trends that can be implemented to generate additional revenue streams for the Fluorescent in Situ Hybridization (FISH) Market?
- What major challenges could the Fluorescent in Situ Hybridization (FISH) Market face in the future?
- What segments are covered in the Fluorescent in Situ Hybridization (FISH) Market?
- Who are the leading companies and what are their portfolios in Fluorescent in Situ Hybridization (FISH) Market?
- What segments are covered in the Fluorescent in Situ Hybridization (FISH) Market?
- Who are the key players in the Fluorescent in Situ Hybridization (FISH) Market?
Browse Related Reports:
Epoxy Curing Agents Market | Size,Share, Growth
Polyolefin Market Size, Trends & Growth Analysis
Alpha-Linolenic Acid Market – Global Industry Analysis and Forecast
Specialty Fats & Oils Market Value | Size,Trends,Forecast|
Water Desalination Equipment Market Demand,Size ,Share, Industry
Floor Coatings Market Size, Analysis and Forecast
3D Scanner Market Size, Share, Trends & Forecast
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
“
